928
Views
0
CrossRef citations to date
0
Altmetric
Interview

Susan Pandya on investigational treatment approaches to cholangiocarcinoma

Pages 291-293 | Received 21 Sep 2020, Accepted 11 Nov 2020, Published online: 10 Dec 2020
 

Disclaimer

The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Taylor & Francis.

Declaration of interest

S Pandya is an employee and stockholder of Agios Pharmaceuticals, Inc.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.